New rapid COVID test aims for 99% accuracy in diagnosis
NCT ID NCT06917261
First seen May 12, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This study tested a new, fast, and affordable COVID-19 test called TestNPass. It uses a nose swab to detect the virus and aims to be as accurate as possible. The study involved 400 adults at a hospital in France. The goal was to see if TestNPass can reliably diagnose SARS-CoV-2 infection, especially for widespread use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital of Grenoble, emergency department
Grenoble, 38700, France
-
University Hospital of Grenoble, infectious disease department
Grenoble, 38700, France
Conditions
Explore the condition pages connected to this study.